The pharmaceutical industry’s commercial model has been under pressure for years. Traditional sales and marketing tactics, such as the in-person sales rep model, have declined under the pressure of rising costs, new regulations, provider consolidation, and increased market complexity. In this video, Strategy& thought leaders explain how pharma companies are responding to these challenges, and how they must adapt to thrive in the future.
A new era for pharmaceuticals: New Commercial Models
Published: June 1, 2015 with Rick Edmunds, Rolf Fricker, Stephan Danner